Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06566209
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
FDG-PET As an Imaging Modality to Diagnose and Risk Stratify Subclinical Imaging Negative Ici-Myocarditis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Positron Emission Tomography for the Detection of Subclinical Immune Checkpoint Inhibitor-Induced Myocarditis PET-SIM a Prospective Single Center Single Arm Open Label Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this pilot study is to evaluate Fluorodeoxyglucose - Positron Emission Tomography FDG-PET as an imaging modality to diagnose and risk stratify subclinical imaging negative ICI-myocarditis and to determine whether subclinical ICI-induced myocarditis is a distinct and clinically relevant entity with a risk of progression to fulminant myocarditis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None